MedTrace Logo

Texting for Relapse Prevention

NCT02819349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-02-20

No results posted yet for this study

Summary

The purpose of this study is to examine whether Texting for Relapse Prevention (T4RP), a text messaging-based early warming for relapse prevention in people who have schizophrenia/SAD, is associated with fewer relapse symptoms compared to a treatment-as-usual control group.

Conditions

Interventions

BEHAVIORAL

Texting for Relapse Prevention (T4RP)

T4RP is a relapse prevention mHealth program text messaging to people who have schizophrenia/SAD. Content is guided by components of the Assertive Community Treatment (ACT) and focuses on facilitating improved patient-provider communication, promoting medication adherence, helping people self-monitor their early warning signs, and promoting self-management of symptoms.

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Center for Innovative Public Health Research

    lead OTHER

Principal Investigators

  • Michele Ybarra, PhD · Center for Innovative Public Health Research (CiPHR)

  • Bernadette Cullen, PhD · Johns Hopkins Community Psychiatry Program (JHCPP)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-12
Primary Completion
2019-04-09
Completion
2019-04-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02819349 on ClinicalTrials.gov